Spyre Therapeutics

Spyre Therapeutics is a private biotechnology company dedicated to advancing a robust pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease (IBD). Spyre Therapeutics combines top-tier antibody engineering, rational therapeutic combinations, and precise immunological approaches to maximize the efficacy, safety, and convenience of IBD treatments.